{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:38:54Z","timestamp":1792269534329,"version":"4.4.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,16]]},"DOI":"10.7759\/cureus.114613","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T19:01:02Z","timestamp":1786906862000},"source":"Crossref","is-referenced-by-count":1,"title":["Suspected Xylazine-Associated Skin Ulcers in Montreal, Canada: A Case Report on Diagnostic Challenges and Multidisciplinary Care"],"prefix":"10.7759","author":[{"given":"Paris","family":"Dastjerdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2885.1988.tb00189.x","article-title":"Xylazine - a review of its pharmacology and use in veterinary medicine","volume":"11","author":"Greene SA","year":"1988","unstructured":"Greene SA, Thurmon JC. Xylazine - a review of its pharmacology and use in veterinary medicine. J Vet Pharmacol Ther. 1988, 11:295-313. 10.1111\/j.1365-2885.1988.tb00189.x","journal-title":"J Vet Pharmacol Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2303120","article-title":"Xylazine - medical and public health imperatives","volume":"388","author":"Gupta R","year":"2023","unstructured":"Gupta R, Holtgrave DR, Ashburn MA. Xylazine - medical and public health imperatives. N Engl J Med. 2023, 388:2209-12. 10.1056\/NEJMp2303120","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2022.2063135","article-title":"Xylazine poisoning: a systematic review","volume":"60","author":"Ball NS","year":"2022","unstructured":"Ball NS, Knable BM, Relich TA, et al.. Xylazine poisoning: a systematic review. Clin Toxicol (Phila). 2022, 60:892-901. 10.1080\/15563650.2022.2063135","journal-title":"Clin Toxicol (Phila)"},{"key":"ref4","unstructured":"Health Canada Drug Analysis Service. The emergence of xylazine in Canada. (2023). Accessed: August 15, 2025: https:\/\/www.canada.ca\/en\/health-canada\/services\/publications\/healthy-living\/emergence-xylazine-canada.html."},{"key":"ref5","unstructured":"Public Health Agency of Canada. Xylazine in apparent drug toxicity deaths. (2025). Accessed: August 15, 2025: https:\/\/health-infobase.canada.ca\/substance-related-harms\/xylazine\/."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.4253","article-title":"Wound characteristics among patients exposed to xylazine","volume":"161","author":"Lutz L","year":"2025","unstructured":"Lutz L, McFadden R, Xu L, et al.. Wound characteristics among patients exposed to xylazine. JAMA Dermatol. 2025, 161:75-80. 10.1001\/jamadermatol.2024.4253","journal-title":"JAMA Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/ASW.0000000000000436","article-title":"Xylazine-associated wounds: a scoping review of clinical presentation and management","volume":"39","author":"Vaile JR","year":"2026","unstructured":"Vaile JR, Connolly WC, Zavitsanos AP, Isch EL, Zavodnick JH, Tannouri S, McMahon HA. Xylazine-associated wounds: a scoping review of clinical presentation and management. Adv Skin Wound Care. 2026, 39:E185-93. 10.1097\/ASW.0000000000000436","journal-title":"Adv Skin Wound Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.24.00534","article-title":"Xylazine-associated necrotic upper-extremity wounds: a single hospital system's experience with 82 patients and 125 wounds","volume":"107","author":"Arango SD","year":"2025","unstructured":"Arango SD, Flynn JC, Zeitlin JH, Weir TB, Miller AJ. Xylazine-associated necrotic upper-extremity wounds: a single hospital system's experience with 82 patients and 125 wounds. J Bone Joint Surg Am. 2025, 107:279-86. 10.2106\/JBJS.24.00534","journal-title":"J Bone Joint Surg Am"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28160","article-title":"Xylazine-induced skin ulcers in a person who injects drugs in Philadelphia, Pennsylvania, USA","volume":"14","author":"Malayala SV","year":"2022","unstructured":"Malayala SV, Papudesi BN, Bobb R, Wimbush A. Xylazine-induced skin ulcers in a person who injects drugs in Philadelphia, Pennsylvania, USA. Cureus. 2022, 14:e28160. 10.7759\/cureus.28160","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2023.04.016","article-title":"Severe cutaneous ulcerations secondary to xylazine (tranq): a case series","volume":"36","author":"Wei J","year":"2023","unstructured":"Wei J, Wachuku C, Berk-Krauss J, Steele KT, Rosenbach M, Messenger E. Severe cutaneous ulcerations secondary to xylazine (tranq): a case series. JAAD Case Rep. 2023, 36:89-91. 10.1016\/j.jdcr.2023.04.016","journal-title":"JAAD Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.58616\/surgicoll.00002","article-title":"Upper extremity soft tissue wound related to xylazine-laced fentanyl intravenous (IV) drug abuse: a case report","volume":"1","author":"Rengifo S","year":"2023","unstructured":"Rengifo S, Ilyas AM, Tosti R. Upper extremity soft tissue wound related to xylazine-laced fentanyl intravenous (IV) drug abuse: a case report. SurgiColl. 2023, 1:1. 10.58616\/surgicoll.00002","journal-title":"SurgiColl"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.58616\/001c.122464","article-title":"Xylazine-induced skin necrosis, emerging public health crisis and the ethical considerations in surgical reconstruction: a case report","volume":"2","author":"Rose K","year":"2024","unstructured":"Rose K, Levy J, Rubenstein R, et al.. Xylazine-induced skin necrosis, emerging public health crisis and the ethical considerations in surgical reconstruction: a case report. SurgiColl. 2024, 2:0. 10.58616\/001c.122464","journal-title":"SurgiColl"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.66609","article-title":"Xylazine-induced necrotic skin ulcers in a fentanyl-injecting individual in South Florida, United States: a case report","volume":"16","author":"Cervantes J","year":"2024","unstructured":"Cervantes J, Khorsandi J, Patel KS, Torrilus C, Izquierdo G, Serota D. Xylazine-induced necrotic skin ulcers in a fentanyl-injecting individual in South Florida, United States: a case report. Cureus. 2024, 16:e66609. 10.7759\/cureus.66609","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-024-00978-z","article-title":"A confirmed case of xylazine-induced skin ulcers in a person who injects drugs in Miami, Florida, USA","volume":"21","author":"Warp PV","year":"2024","unstructured":"Warp PV, Hauschild M, Serota DP, Ciraldo K, Cruz I, Bartholomew TS, Tookes HE. A confirmed case of xylazine-induced skin ulcers in a person who injects drugs in Miami, Florida, USA. Harm Reduct J. 2024, 21:64. 10.1186\/s12954-024-00978-z","journal-title":"Harm Reduct J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.36518\/2689-0216.1695","article-title":"A case of xylazine-induced necrotic skin ulcerations in an IV-drug user in Florida","volume":"5","author":"Zaki M","year":"2024","unstructured":"Zaki M, Dillon C, Patel A, Gracious B. A case of xylazine-induced necrotic skin ulcerations in an IV-drug user in Florida. HCA Healthc J Med. 2024, 5:713-9. 10.36518\/2689-0216.1695","journal-title":"HCA Healthc J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001198","article-title":"Recognition and treatment of wounds in persons using xylazine: a case report from New Haven, Connecticut","volume":"17","author":"Dowton A","year":"2023","unstructured":"Dowton A, Doernberg M, Heiman E, et al.. Recognition and treatment of wounds in persons using xylazine: a case report from New Haven, Connecticut. J Addict Med. 2023, 17:739-41. 10.1097\/ADM.0000000000001198","journal-title":"J Addict Med"},{"key":"ref17","unstructured":"Xylazine test strip (urine). (2023). Accessed. August 15, 2025: https:\/\/www.btnx.com\/product\/xylazine-test-strip-urine."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.51731\/cjht.2023.691","article-title":"Xylazine test strips for drug checking","volume":"3","author":"Jones S","year":"2023","unstructured":"Jones S, Bailey S. Xylazine test strips for drug checking. Can J Health Technol. 2023, 3:7. 10.51731\/cjht.2023.691","journal-title":"Can J Health Technol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000001245","article-title":"Xylazine-associated wounds: clinical experience from a low-barrier wound care clinic in Philadelphia","volume":"18","author":"McFadden R","year":"2024","unstructured":"McFadden R, Wallace-Keeshen S, Petrillo Straub K, Hosey RA, Neuschatz R, McNulty K, Thakrar AP. Xylazine-associated wounds: clinical experience from a low-barrier wound care clinic in Philadelphia. J Addict Med. 2024, 18:9-12. 10.1097\/ADM.0000000000001245","journal-title":"J Addict Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/SAP.0000000000004616","article-title":"Surgical management of xylazine-associated wounds: a retrospective review and algorithmic approach","volume":"96","author":"Makhoul AT","year":"2026","unstructured":"Makhoul AT, Morales CZ, Card EB, et al.. Surgical management of xylazine-associated wounds: a retrospective review and algorithmic approach. Ann Plast Surg. 2026, 96:S359-64. 10.1097\/SAP.0000000000004616","journal-title":"Ann Plast Surg"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/514798-suspected-xylazine-associated-skin-ulcers-in-montreal-canada-a-case-report-on-diagnostic-challenges-and-multidisciplinary-care","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T19:01:03Z","timestamp":1786906863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/514798-suspected-xylazine-associated-skin-ulcers-in-montreal-canada-a-case-report-on-diagnostic-challenges-and-multidisciplinary-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,16]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.114613","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,16]]}}}